close
read more
Our group
Governance
Global presence
Key figures
History
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay R&D Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Third-Party Sponsor studies
Business development & licensing
Our commitments
Patient
Ethics
Compliance policy
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
Press
News
Press
02 / 08 / 2019
Press Release of 6 july 2018